Research graph
References from Implications of urinary albumin-to-creatinine ratio for subsequent kidney function decline and kidney-related outcomes in patients hospitalized for worsening heart failure: Insights from the JROADHF-NEXT registry. Local targets link to admitted publications; unresolved targets remain external evidence.
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions
10.1002/ejhf.566 · 2016 · External reference
Home-Time, Mortality, and Readmissions Among Patients Hospitalized With Heart Failure: A Baseline Prior to IMPLEMENT-HF
10.1161/circheartfailure.124.011795 · 2024 · External reference
Clinical characteristics and outcomes of hospitalized patients with heart failure from the Japanese prospective registry
2025 · External reference
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
10.1093/eurheartj/eht386 · 2014 · External reference
Trajectories of Kidney Function in Heart Failure Over a 15-Year Follow-Up: Clinical Profiling and Mortality
10.1016/j.jchf.2024.01.004 · 2024 · External reference
Renal function and target organ damage in hypertension
10.1093/eurheartj/ehr003 · 2011 · External reference
Change in albuminuria as a surrogate endpoint for cardiovascular and renal outcomes in patients with diabetes
10.1111/dom.15030 · 2023 · External reference
Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
2024 · External reference
The pathogenesis of proteinuria in the acutely congested kidney
10.1172/jci103127 · 1955 · External reference
Albuminuria as a marker of systemic congestion in patients with heart failure
10.1093/eurheartj/ehac528 · 2023 · External reference
Albuminuria and Heart Failure: JACC State-of-the-Art Review
10.1016/j.jacc.2022.10.028 · 2023 · External reference
Albuminuria as a diagnostic criterion and a therapeutic target in heart failure and other cardiovascular disease
10.1002/ejhf.3683 · 2025 · External reference
Albuminuria in chronic heart failure: prevalence and prognostic importance
10.1016/s0140-6736(09)61378-7 · 2009 · External reference
Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: data from the GISSI-Heart Failure trial
10.1161/circheartfailure.109.881805 · 2010 · External reference
Prognostic impact of subclinical microalbuminuria in patients with chronic heart failure
10.1253/circj.cj-14-0787 · 2014 · External reference
Angiotensin-neprilysin inhibition versus enalapril in heart failure
10.1056/nejmoa1409077 · 2014 · External reference
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction
10.1093/eurheartj/ehab798 · 2022 · External reference
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
10.1038/s41591-022-01971-4 · 2022 · External reference
Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled
10.1001/jamacardio.2022.2924 · 2022 · External reference
Frailty Scale Captures Multidimensional Vulnerability and Predicts Mortality in Heart Failure
2025 · External reference
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction: Results of DAPA-HF
10.1161/circulationaha.120.050391 · 2021 · External reference
Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from the EMPEROR-Preserved trial
10.1002/ejhf.2857 · 2023 · External reference
A predictive model for progression of chronic kidney disease to kidney failure
10.1001/jama.2011.451 · 2011 · External reference
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis
10.1001/jama.2015.18202 · 2016 · External reference
IDDM patients with microalbuminuria. The Microalbuminuria Captopril Study Group
10.1007/bf00403306 · 1996 · External reference
Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy
10.1046/j.1523-1755.2000.00224.x · 2000 · External reference
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
10.1016/s2213-8587(17)30182-1 · 2017 · External reference
Prognostic Value of Albuminuria and Influence of Spironolactone in Heart Failure With Preserved Ejection Fraction
10.1161/circheartfailure.118.005288 · 2018 · External reference
A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program
10.1161/circoutcomes.109.854877 · 2010 · External reference
Clinical Significance of Get With the Guidelines-Heart Failure Risk Score in Patients With Chronic Heart Failure After Hospitalization
10.1161/jaha.117.008316 · 2018 · External reference
Angiotensin-neprilysin inhibition and renal outcomes across the spectrum of ejection fraction in heart failure
10.1002/ejhf.2421 · 2022 · External reference
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical Trial
10.1001/jamacardio.2022.4210 · 2023 · External reference
Finerenone and Kidney Outcomes in Patients With Heart Failure: The FINEARTS-HF Trial
10.1016/j.jacc.2024.10.091 · 2025 · External reference
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts
10.1038/ki.2010.550 · 2011 · External reference
Early evolution and correlates of urine albumin excretion in patients presenting with acutely decompensated heart failure
10.1161/circheartfailure.112.000152 · 2013 · External reference
Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement
10.1016/j.jacc.2023.01.049 · 2023 · External reference
Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study
10.1093/eurjhf/hfs001 · 2012 · External reference
Albuminuria: Associated With Heart Failure Severity and Impaired Clinical Outcomes
2020 · External reference
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF
10.1002/ejhf.531 · 2016 · External reference
Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction
10.1093/eurheartj/ehaf457 · 2025 · External reference
